These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1827009)

  • 1. Effect of isradipine on 24-h blood pressure profile demonstrated by repeated monitoring.
    Cihák R; Widimský J; Lefflerová K; Janský P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):158S-160S. PubMed ID: 1827009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24-hour ambulatory blood pressure monitoring in the treatment of mild hypertension with isradipine.
    Cihák R; Widimský J; Janský P; Lefflerová K
    Cor Vasa; 1990; 32(2 Suppl 1):54-60. PubMed ID: 2143460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Faraggi D
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of isradipine slow release given once daily with isradipine twice daily on 24 hour blood pressure in hypertensive patients.
    Christensen HR; Kampmann JP; Simonsen K
    J Hum Hypertens; 1991 Apr; 5(2):121-7. PubMed ID: 1830108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
    Nelson EB; Pool JL; Taylor AA
    Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of isradipine on ambulatory and casual blood pressure.
    Fitscha P; Meisner W
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):67S-69S. PubMed ID: 8466731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does isradipine exert a special early-morning blood pressure-lowering effect?
    Viskoper JR; Laszt A; Faraggi D; Yaskil E
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S74-5. PubMed ID: 1376842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
    Welzel D; Burger KJ
    Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circadian antihypertensive effect of sustained-release isradipine in patients with essential hypertension in comparison to placebo].
    Burger KJ; Anlauf M
    Arzneimittelforschung; 1993 Sep; 43(9):958-62. PubMed ID: 8240458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].
    Lohmann FW; Welzel D; Burger KJ
    Arzneimittelforschung; 1993 May; 43(5):522-5. PubMed ID: 8328996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D; Burger KJ; Weidinger G
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations.
    Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko MK; Wiesner RH; Krom RA
    Am J Hypertens; 2000 Mar; 13(3):231-9. PubMed ID: 10777026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure.
    Lacourcière Y; Poirier L; Dion D; Provencher P
    Am J Cardiol; 1990 Feb; 65(7):467-72. PubMed ID: 2137666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
    Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.